Screener
CeriBell, Inc. CBLL Q3 2026 earnings
Reported November 3, 2026 · After market close
Revenue$29.3MBeat by $162.1K
EPS-$0.55Miss by $0.04
Revenue estimate$29.2M
EPS estimate-$0.51
“Our third quarter results reflect new highs in account additions and utilization within our existing account base, demonstrating the strength of our core seizure business as a durable growth engine, With the full launch of our delirium monitoring solution and the coming introduction of our new hardware platform, we are well positioned for a pivotal 2027 as we advance our mission to establish EEG as a new vital sign.”
Next report
Date not yet announcedValuation & ratios
Segments
By product
Versus estimates
Revenue
Diluted EPS
FAQ
- When did CeriBell, Inc. report Q3 2026 earnings?
- CeriBell, Inc. (CBLL) reported Q3 2026 earnings on November 3, 2026 after market close.
- What were CeriBell, Inc.'s Q3 2026 revenue and EPS?
- CeriBell, Inc. reported revenue of $29.3M and eps of $-0.55 for Q3 2026.
- Did CeriBell, Inc. beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $29.2M by $162.1K. EPS missed the consensus estimate of $-0.51 by $0.04.
- How did CeriBell, Inc.'s Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 29.9% from $22.6M a year earlier and eps declined 48.6% from $-0.37.
- Where can I find CeriBell, Inc.'s Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-445487) and the 10-Q periodic report (0001193125-26-445555) directly on SEC EDGAR. The filing index links above go to sec.gov.
